Allogeneic Cardiosphere-Derived Cells (CAP-1002)
CAP-1002-DMD-01
Phase 2 small_molecule completed
Quick answer
Allogeneic Cardiosphere-Derived Cells (CAP-1002) for Duchenne Muscular Dystrophy is a Phase 2 program (small_molecule) at CAPRICOR THERAPEUTICS, INC. with 2 ClinicalTrials.gov record(s).
Program details
- Company
- CAPRICOR THERAPEUTICS, INC.
- Indication
- Duchenne Muscular Dystrophy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed